• Print

released: 25 Feb 2010 author: AIHW media release

Medicines are central to managing arthritis and osteoporosis, to improve musculoskeletal functions, slow disease progression and reduce pain and inflammation. Pharmaceutical innovations over the last several years have improved the efficacy and diversity of medicines available to manage these conditions. However, the adoption of new and more effective drugs is often costly. This report provides information on what medicines Australians areusing to manage their musculoskeletal problems, how much do these medicines cost them and trends in the prescription of newer medicines.

ISSN 1833-0991; ISBN 978 1 74024 997 3; Cat. no. PHE 121; 92pp.; Internet only

Full publication

Publication table of contents

  • Preliminary material (198KB PDF)
    • Title and verso pages
    • Contents
    • Abbreviations
    • Summary
  • Body section (330KB PDF)
    1. Introduction
      • Management of arthritis and osteoporosis
      • Structure of this report
      • Data sources
    2. Arthritis and osteoporosis in Australia
      • Major medication groups
      • Medication use by area of residence
    3. Pharmacotherapy of osteoarthritis
      • What is osteoarthritis?
      • The extent of osteoarthritis in Australia
      • Pharmacotherapy
      • Pharmaceutical medicines
      • Complementary medicines
      • Trends in medications recommended by GPs
      • Expenditure
      • New treatments and COX-2 inhibitor recall
    4. Pharmacotherapy of rheumatoid arthritis
      • What is rheumatoid arthritis?
      • The extent of rheumatoid arthritis in Australia
      • Pharmacotherapy
      • New medicines and PBS restrictions
      • Pharmaceutical medicines
      • Complementary medicines
      • Trends in medications recommended by GPs
      • Management of new cases
      • Expenditure
    5. Pharmacotherapy of osteoporosis
      • What is osteoporosis?
      • The extent of osteoporosis in Australia
      • Pharmacotherapy
      • Pharmaceutical medicines
      • Complementary medicines
      • Trends in medications recommended by GPs
      • Expenditure
      • Changes to the PBS and other medications
    6. References
  • End matter (247KB PDF)
    • Appendixes
      1. Description of medicines
        • Analgesics
        • Anti-resorptives
        • Complementary medicines
        • Corticosteroids
        • Disease-modifying anti-rheumatic drugs (DMARDs)
        • Non-steroidal anti-inflammatory drugs (NSAIDs) and COX-2 inhibitors
        • Other medications
      2. Data sources and methodology
        • Data sources
        • Statistical methods
      3. Statistical tables
      4. APBS restrictions for biological DMARDs (bDMARDs)
      5. Usual area of residence-remoteness
    • List of tables
    • List of figures
    • List of boxes

Recommended citation

AIHW 2010. Medication use for arthritis and osteoporosis. Arthritis series no. 11. Cat. no. PHE 121. Canberra: AIHW. Viewed 30 May 2017 <http://www.aihw.gov.au/publication-detail/?id=6442468332>.

Request an alternative format

Please contact us if you need information from the website presented in an alternative format for accessibility reasons.